Structural basis for reaction mechanism and drug delivery system of chromoprotein antitumor antibiotic C-1027

Journal of the American Chemical Society

Volumn 122, Issue 29, 2000, Pages 6848-6854

  Okuno, Yasushi ^a   Iwashita, Takashi ^b   Sugiura, Yukio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC C 1027; ANTINEOPLASTIC AGENT; APOPROTEIN; CARRIER PROTEIN;

ARTICLE; DNA CONFORMATION; DRUG CONFORMATION; DRUG DELIVERY SYSTEM; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; PROTEIN DNA INTERACTION;

EID: 0034718061     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja994323a     Document Type: Article

References (32)

1. (a) McHugh, M. M.; Beerman, T. A.; Burhans, W. C. Biochemistry 1997, 36, 1003-1009.
2. (b) Hu, J.; Xue, Y.-C.; Xie, M.-Y.; Zhang, R.; Otani, T.; Yamada, Y.; Marunaka, T. J. Antibiot. (Tokyo) 1988, 41, 1575-1579.
3. (c) Zhen, Y.-S.; Ming, X.-Y.; Yu, B.; Otani, T.; Saito, H.; Yamada, Y. J. Antibiot. (Tokyo) 1989, 42, 1294-1298.
4. (a) Okuno, Y.; Otsuka, M.; Sugiura, Y. J. Med. Client. 1994, 37, 2266-2273.
5. (b) Otani, T.; Minami, Y.; Marunaka, T.; Zhang, R.; Xie, M.Y. ]. Antibiot. (Tokyo) 1988, 4l, 1580-1585.
6. Matsumoto, T.; Okuno, Y.; Sugiura, Y. Biochem. Biophys. Res. Commun. 1993, 795, 659-666.
7. Kappen, L. S.; Goldberg, I. H. Science 1993, 261, 1319-1321.
8. (a) Xu, J.; Wu, J.; Dedon P. C. Biochemistry 1998, 37, 1890-1897.
9. (b) Kumar, R. A.; Ikemoto, N.; Patel, D. J. J. Mol. Biol. 1997, 265, 173186.
10. Kumar, R. A.; Ikemoto, N.; Patel, D. J. J. Mol. Biol. 1997, 265, 187201.
11. Zein, N.; Colson, K. L.; Leet, J. E.; Schroeder, D. R.; Solomon, W.; Doyle, T. W.; Casazza, A. M. Proc. Natl. Acad. Sci. U.SA. 1993, 90, 28222826.
12. Okuno, Y.; Iwashita, T.; Otani, T.; Sugiura, Y. J. Am. Chem. Soc. 1996, 118, 4729-4730.
13. Sugiura, Y.; Matsumoto, T. Biochemistry 1993, 32, 5548-5553.
14. (a) McHugh, M. M.; Woynarowski, J. M.; Gawron, L. S.; Otani, T.; Beerman, T. A. Biochemistry 1995, 34, 1805-1814.
15. (b) Cobuzzi, R. J.; Kotsopoulos, S. K.; Otani, T.; Beerman, T. A. Biochemistry 1995, 34, 583592.
16. Xu, Y. J.; Zhen, Y. S.; Goldberg, I. H. Biochemistry 1994, 33, 59475954.
17. lida, K.; Hirama, M. J. Am. Chem. Soc. 1995, 777, 8875-8876.
18. lida, K.; Fukuda, S.; Tanaka, T.; Hirama, M.; Imajo, S.; Ishiguro, M.; Yoshida, K.; Otani, T. Tetrahedron Lett. 1996, 37, 4997-5000.
19. Piotto, M.; Sandek, V.; Sklenar, V. J. Biomol. NMR 1992, 2, 661665.
20. Wuthrich, K., NMR of Proteins and Nucleic Acids; Wiley: New York, 1986.
21. Kessler, H.; Bats, J. W.; Griesinger, C.; Roll, S.; Will, M.; Wagner, K. J. Am. Chem. Soc. 1988, 110, 1033-1049.
22. Yu, L.; Mah, S.; Otani, T.; Dedon, P. J. Am. Chem. Soc. 1995, 117, 8877-8878.
23. We used the structure coordinates of the Chr-Apo complex supplied by Dr. Ishiguro. The coodinates were derived for the aromatized Chr-Apo complex.
24. Matsumoto, T.; Sugiura, Y. Biochem. Biophys. Res. Commun. 1994, 205, 1533-1538. In preliminary experiments of DNA-Chr titration, we tried various kinds of DNA oligomers containing GTTAT/ATAAC, CTTTT/ AAAAG, ATAAT/ATTAT, CTTTA/TAAAG, and CTCJT/AAGAG. However, the imino proton-spectral region of complexes of Chrs with most oligomers except for d(TGCCATC)/d(GATGGCA) exhibited nonstoichiometric or broadening resonaces, indicating formation of multiple conformations of complex in each case. Namely, other duplexes except for d(TGCCATC)/d(GATGGCA) contain multiple binding sites despite single cleavage site by the Chr. The drug bound to a DNA sequence cannot always abstract the hydrogen atoms of the DNA nucleotides. Therefore, the 2-amino group of the central G is important to enhance specificity of DNA target recognition (not cleavage) by C1027-Chr.
25. lida and Hirama reported that the constraint of the nine-membered ring of C1027-Chr may contribute to lowering the barrier for interconversion between the enediyne and biradical forms, and consequently the reaction process becomes reversible at ambient temperature. The hydrogen abstraction step by a biradical form is kinetically significant in the cycloaromatization of C1027-Chr. Therefore, the reactivity of C-1027 is affected more directly by conformation of aromatized form analogous to the biradical intermediate rather than by that of enediyne form.
26. (a) Cramer, C. J.; Squires, R. R. J. Phys. Chem. 1997, A101, 91919194.
27. (b) Cramer, C. J.; Nash, J. J.; Squires, R. R. Chem. Pliys. Lett. 1997, 277, 311-320.
28. Logan, C. F.; Chen, P. J. Ain. Chem. Soc. 1996, 118, 2113-2114.
29. We used the benzene ring as a group adjcent to p-benzyne biradical for the purpose of the simplicity of ab initio calculation. If chlorophenol ring is employed instead of benzen ring, the functional substituent groups (chloro- and hydroxyl-group) may influence the magnitude of S-T splitting difference for the two C1027-Chr form. Therefore, the calculated S-T gap difference (~0.04) can indicate qualitative tendency of the C1027reactivity. More accurate calculations will lead to these quantitative interpretations.
30. (a) Stassinopoulos, A.; Ji, J.; Gao, X.; Goldberg, I. H. Science 1996, 272, 1943-1946.
31. (b) Gao, X.; Stassinopoulos, A.; Rice, J. S.; Goldberg, I. H. Biochemistry 1995, 34, 40-49.
32. (c) Kirn, K.-H.; Kwon, B.-H.; Myers, A. G.; Rees, D. C. Science 1993, 262, 1042-1046.